scPharmaceuticals Inc (SCPH)
4.74
-0.08
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Total Liabilities (Quarterly): 53.89M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 53.89M |
December 31, 2023 | 57.26M |
September 30, 2023 | 56.96M |
June 30, 2023 | 50.74M |
March 31, 2023 | 51.56M |
December 31, 2022 | 51.76M |
September 30, 2022 | 17.29M |
June 30, 2022 | 18.70M |
March 31, 2022 | 19.50M |
December 31, 2021 | 22.57M |
September 30, 2021 | 24.42M |
June 30, 2021 | 24.57M |
March 31, 2021 | 24.78M |
December 31, 2020 | 26.88M |
Date | Value |
---|---|
September 30, 2020 | 27.14M |
June 30, 2020 | 25.86M |
March 31, 2020 | 25.38M |
December 31, 2019 | 25.92M |
September 30, 2019 | 28.78M |
June 30, 2019 | 19.99M |
March 31, 2019 | 17.19M |
December 31, 2018 | 15.01M |
September 30, 2018 | 15.43M |
June 30, 2018 | 16.42M |
March 31, 2018 | 15.71M |
December 31, 2017 | 16.05M |
September 30, 2017 | 14.28M |
December 31, 2016 | 76.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.29M
Minimum
Sep 2022
57.26M
Maximum
Dec 2023
32.70M
Average
25.89M
Median
Total Liabilities (Quarterly) Benchmarks
Anika Therapeutics Inc | 55.21M |
Spero Therapeutics Inc | 71.45M |
electroCore Inc | 9.394M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 78.45M |
Shareholders Equity (Quarterly) | 24.57M |
Debt to Equity Ratio | 1.603 |
Current Ratio | 6.212 |
Net Debt Paydown Yield | -0.15% |